Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Mycophenolate Mofetil Attenuates DOCA-Salt Hypertension: Effects on Vascular Tone.

Moes AD, Severs D, Verdonk K, van der Lubbe N, Zietse R, Danser AHJ, Hoorn EJ.

Front Physiol. 2018 May 18;9:578. doi: 10.3389/fphys.2018.00578. eCollection 2018.

2.

Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats.

Boesen EI, Williams DL, Pollock JS, Pollock DM.

Clin Exp Pharmacol Physiol. 2010 Oct;37(10):1016-22. doi: 10.1111/j.1440-1681.2010.05428.x.

3.

Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure.

Rodríguez-Iturbe B, Pons H, Quiroz Y, Gordon K, Rincón J, Chávez M, Parra G, Herrera-Acosta J, Gómez-Garre D, Largo R, Egido J, Johnson RJ.

Kidney Int. 2001 Jun;59(6):2222-32.

4.

Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.

Matsumura Y, Hashimoto N, Taira S, Kuro T, Kitano R, Ohkita M, Opgenorth TJ, Takaoka M.

Hypertension. 1999 Feb;33(2):759-65.

PMID:
10024341
5.
6.

Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats.

Dai SY, Peng W, Zhang YP, Li JD, Shen Y, Sun XF.

J Neuroinflammation. 2015 Mar 8;12:47. doi: 10.1186/s12974-015-0261-4.

7.

Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition.

Quiroz Y, Pons H, Gordon KL, Rincón J, Chávez M, Parra G, Herrera-Acosta J, Gómez-Garre D, Largo R, Egido J, Johnson RJ, Rodríguez-Iturbe B.

Am J Physiol Renal Physiol. 2001 Jul;281(1):F38-47.

8.

TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.

Elmarakby AA, Quigley JE, Imig JD, Pollock JS, Pollock DM.

Am J Physiol Regul Integr Comp Physiol. 2008 Jan;294(1):R76-83. Epub 2007 Nov 7.

9.
10.
11.

Immunosuppression preserves renal autoregulatory function and microvascular P2X(1) receptor reactivity in ANG II-hypertensive rats.

Guan Z, Giddens MI, Osmond DA, Cook AK, Hobbs JL, Zhang S, Yamamoto T, Pollock JS, Pollock DM, Inscho EW.

Am J Physiol Renal Physiol. 2013 Mar 15;304(6):F801-7. doi: 10.1152/ajprenal.00286.2012. Epub 2012 Dec 26.

12.

Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats.

Pollock DM, Allcock GH, Krishnan A, Dayton BD, Pollock JS.

Am J Physiol Renal Physiol. 2000 Feb;278(2):F279-86.

13.

Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats.

David FL, Carvalho MH, Cobra AL, Nigro D, Fortes ZB, Rebouças NA, Tostes RC.

Hypertension. 2001 Sep;38(3 Pt 2):692-6.

PMID:
11566958
14.

Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.

Wada T, Kanagawa R, Ishimura Y, Inada Y, Nishikawa K.

J Hypertens. 1995 Jan;13(1):113-22. Erratum in: J Hypertens 1996 Dec;14(12):1493.

PMID:
7759841
15.

Omapatrilat increases renal endothelin in deoxycorticosterone acetate-salt hypertensive rats.

Elmarakby AA, Morsing P, Pollock JS, Pollock DM.

Vascul Pharmacol. 2003 Dec;40(5):253-9.

PMID:
15259792
16.

Deoxycorticosterone suppresses the effects of losartan in nitric oxide-deficient hypertensive rats.

de Gracia MC, Osuna A, O'Valle F, del Moral RG, Wangensteen R, del Rio CG, Vargas F.

J Am Soc Nephrol. 2000 Nov;11(11):1995-2000.

17.

Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.

Nishimura M, Ohtsuka K, Sakamoto M, Nanbu A, Takahashi H, Yoshimura M.

J Hypertens. 1998 Aug;16(8):1175-85.

PMID:
9794722
18.

PCSK9-deficiency does not alter blood pressure and sodium balance in mouse models of hypertension.

Berger JM, Vaillant N, Le May C, Calderon C, Brégeon J, Prieur X, Hadchouel J, Loirand G, Cariou B.

Atherosclerosis. 2015 Mar;239(1):252-9. doi: 10.1016/j.atherosclerosis.2015.01.012. Epub 2015 Jan 19.

PMID:
25621930
20.

Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate-salt hypertension.

Hisamichi M, Kamijo-Ikemori A, Sugaya T, Ichikawa D, Natsuki T, Hoshino S, Kimura K, Shibagaki Y.

FASEB J. 2017 Jan;31(1):72-84. doi: 10.1096/fj.201600684RR. Epub 2016 Sep 23.

Supplemental Content

Support Center